This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Sanofi. Active years: 2015-2017.
Company Filing History:
Years Active: 2015-2017
Title: Aurelie Strub: Innovator in VEGF Receptor Kinase Inhibitors
Introduction
Aurelie Strub is a prominent inventor based in Paris, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific biological pathways. With a total of 2 patents, her work focuses on innovative solutions for therapeutic applications.
Latest Patents
Aurelie Strub's latest patents include the development of 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors. These inventions relate to compounds of general formula (I) and encompass both the preparation process and therapeutic use. Her research aims to provide new avenues for treating diseases associated with abnormal vascular growth.
Career Highlights
Aurelie is currently employed at Sanofi, a leading global healthcare company. Her role involves extensive research and development in the pharmaceutical sector, where she applies her expertise to create innovative therapeutic solutions. Her contributions have been instrumental in advancing the company's portfolio of medicinal products.
Collaborations
Aurelie has collaborated with notable colleagues, including Alain Jean Braun and Olivier Duclos. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking innovations in the field.
Conclusion
Aurelie Strub is a trailblazer in the realm of medicinal chemistry, with a focus on VEGF receptor kinase inhibitors. Her patents and work at Sanofi highlight her commitment to advancing healthcare through innovative research. Her contributions are paving the way for future developments in therapeutic applications.